Improving Care for Children with Epilepsy Through New Approaches
This study looked at different types of interventions aimed at helping children with epilepsy, focusing on service delivery, behavioral therapies, and self-management techniques.
-
-
Improving Tonic Seizure Detection with Automatic Systems
This study looked at how well automatic systems can detect tonic seizures, which are a type of seizure where the muscles stiffen.
-
Seizure Frequency Reduces Over Time in Treatment-Resistant Epilepsy
A study was conducted to understand how seizure frequency changes over time in people with treatment-resistant focal epilepsy (FTRE).
-
Monitoring Levetiracetam in Pregnancy Needs Standardized Guidelines
Researchers studied how levetiracetam, a common medication for epilepsy, is monitored during pregnancy.
-
New Insights on DEPDC5-Related Epilepsy for Better Care
This study looked at a specific genetic cause of focal epilepsy called DEPDC5 variants, which are often linked to brain abnormalities.
-
Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | New Studies | Safety & First Aid
Ivermectin Shows Promise for Treating Drug-Resistant Epilepsy
Researchers studied the effects of Ivermectin (IVM) on patients with drug-resistant epilepsy, which means their seizures are hard to control even with multiple medications.
-
Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Imaging & EEG | New Studies
New Approaches to Deep Brain Stimulation for Epilepsy Care
Researchers studied how deep brain stimulation (DBS) and responsive neurostimulation (RNS) can help people with drug-resistant epilepsy (DRE), which is epilepsy that doesn’t respond to medications.
-
NBEA Gene Variant Linked to Developmental Delays and Seizures
Researchers studied a specific genetic change in the NBEA gene in a child from China who had developmental delays and epilepsy.
-
Parents Prioritize Improving Communication for Children with Severe Conditions
This study looked at how non-seizure outcomes affect young people with severe neurodevelopmental encephalopathy, with or without epilepsy.
